InvestorsHub Logo
Followers 155
Posts 2641
Boards Moderated 0
Alias Born 01/29/2004

Re: powerwalker post# 427313

Monday, 08/14/2023 2:49:09 PM

Monday, August 14, 2023 2:49:09 PM

Post# of 462126
But, the FDA will be wrong with blarcamesine.

Also, it is questionable how much assistance DPZ provides after 6 month or 26 weeks.


However, it's FDA approved, so the matter is settled. Things not FDA approved, such as Anavex's sigma-1 receptor activators ("agonists"), simply can't work. Neither science nor patient anecdotes settle the matter; only the imprimatur of FDA approval.

Except, of course, after the FDA actually approves either blarcamesine or Anavex 3-71. When that happens, on the basis of the many postings over the years, here, that Anavex science is a fraud, might we expect our message board experts to tell us that the FDA has made a great error, that blarcamesine should never be approved for any human disease? Let's watch....
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News